The global peripheral atherectomy devices market size is estimated to increase over the forecast period to exceed $1.1 billion in 2027. The global coronary atherectomy devices market size is expected to reach over $947.4 million in 2027. The majority of the global atherectomy device market share was controlled by Medtronic and Boston Scientific. Overall, this

In 2020, the European interventional cardiology market size was valued at approximately €928 million, down from nearly €1.2 billion in 2019 due to the impact of COVID-19. The European market size is expected to decrease over the forecast period and reach €1 billion in 2026. Over 50% of the European interventional cardiology market share was

In 2019, the global Intravascular ultrasound market size was valued at $565 million, with the majority of the market being coronary IVUS catheters. In spite of COVID19, the global market size is expected to increase over the forecast period to exceed an astonishing $1 billion in 2027. Over 60% of the global IVUS market share

In 2020, the global interventional cardiology market size was valued at approximately $11.1 billion, down from nearly $14 billion in 2019 due to the impact of COVID-19. The global market size is expected to reach an astonishing $16.2 billion in 2027. Over 40% of the global interventional cardiology market share was controlled by Boston Scientific,

In 2020, the U.S. interventional cardiology device market size was valued at approximately $3.2 billion, with over 965,000 PCI procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $4.1 billion by 2026. Throughout this medical market research, we analyzed 43 interventional cardiology

Industry Trends There is a risk that the placement or introduction of a device during an interventional coronary procedure can dislodge thrombi or emboli, which could create health risks for the patient that the interventional procedure is intended to prevent. In response to these concerns, many different approaches were taken to deal with this problem,

Carotid stenting can be accompanied with plaque dislodgment and plaque emboli. Thus, the initial popularity of carotid stents was tainted as these artifacts caused an unacceptably high incidence rate of strokes. Since then, the industry has responded by manufacturing embolic protection devices (EPDs). These devices are used to capture dislodged vascular debris.

Atherectomy procedures are used to remove plaque from arteries and reestablish blood flow. Occasionally, atherectomy is referred to as ablation or plaque debulking. Coronary atherectomy devices are used when there is calcification in the arteries, and the procedure is mostly performed in grafts. Atherectomy was originally developed for the treatment of coronary arteries, later expanding to the peripheral market.

The full report suite on the U.S. market for interventional cardiology devices includes analysis on the coronary stent, coronary balloon catheter, balloon-inflation device, interventional coronary catheter, interventional coronary guidewire, coronary embolic protection device, coronary atherectomy device, coronary thrombectomy device, chronic total occlusion system, introducer
sheath, coronary vascular closure device, diagnostic coronary catheter and guidewire, intravascular ultrasound (IVUS) and optical coherence tomography (OCT) markets.

Optical coherence tomography (OCT) is an imaging modality that can create extremely high resolution, three-dimensional images of biological tissues, which has proven to be very effective for interventional purposes. While OCT has been used for a number of years in other medical fields, such as in ophthalmology, it has only recently been applied to cardiology. In 2014, only a few OCT systems were approved by the FDA for use in cardiology. However, OCT systems were being used for producing high-resolution images of arteries in a clinical setting since 2006 in Japan and Europe.

Vascular closure devices (VCDs) are used in both the peripheral and coronary markets for minimally invasive cardiovascular therapies, which has created a large market for post-procedural VCDs. The introduction of a catheter into the arterial system, to place a stent for example, is much less traumatic for the patient than a comparable surgical intervention, with only a hole created in the artery (generally the femoral) for access. This access hole will bleed profusely if unmanaged, and therefore some form of vascular closure is required.

Introducer sheaths facilitate the insertion of devices, such as guidewires and catheters, for use in interventional procedures. They are tube-shaped and are generally inserted by nurses. Introducer sheaths can also simplify the application of patches and closure devices at the end of procedures to allow hemostasis to occur. Introducer sheaths are sold in a wide range of sizes to fit patient requirements. They need to have kick resistance and an elongated shape that protects vessels from injuries. In addition, introducer sheaths need to have a transparent structure to allow visualization.

The vast majority of IVUS catheters are used immediately before, during or after an angioplasty procedure. Intravascular ultrasound (IVUS) catheters are used in conjunction with minimally invasive cardiovascular procedures. Procedures utilizing IVUS catheters must be performed in catheterization laboratories (cath labs) that have an IVUS console. These consoles are typically integrated into the cath lab infrastructure and are not portable.

Interventional catheters are used by physicians in procedures for the placement of devices such as stents and balloons. There is a large variety of catheters, and their use depends on the size, shape and curvature of the lesion. Cardiologists tend to choose catheters based on their guidewire selection. Interventional catheters must be rigid without being stiff, because the device must adapt itself to the curvature of certain arteries.

Interventional guidewires are often the first type of device to cross an arterial lesion. For this reason, the choice of guidewire is extremely important in order for a procedure to be successful. Interventional guidewires used for coronary applications can be classified into two general types: conventional and specialty guidewires.

Coronary diagnostic screenings, or angiography procedures, utilize X-ray images for the visualization of arteries and chambers of the heart. A contrast agent is inserted into the patient’s veins in order to screen and monitor blood flow during a procedure. The contrast agent travels through the patient’s body via a diagnostic catheter, whose placement at the opening of the coronary arteries is facilitated through the aid of a guidewire.